Mechanisms promoting escape from mitotic stress-induced tumor cell death

Rebecca Sinnott, Leah Winters, Brittany Larson, Daniela Mytsa, Patrick Taus, Kathryn M. Cappell, Angelique W. Whitehurst

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about themolecular underpinnings of the intrinsic resistance of chemo-naïve NSCLC. Herewe report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling ofmitotic defects fromapoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, whichmay promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.

Original languageEnglish (US)
Pages (from-to)3857-3869
Number of pages13
JournalCancer Research
Volume74
Issue number14
DOIs
StatePublished - Jul 15 2014

Fingerprint

Non-Small Cell Lung Carcinoma
Cell Death
M Phase Cell Cycle Checkpoints
RNA Interference
Paclitaxel
Neoplasms
Spindle Poles
Chromosome Segregation
Poisons
Microtubules
Polymerization
Cluster Analysis
Genome
Lung
Therapeutics
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sinnott, R., Winters, L., Larson, B., Mytsa, D., Taus, P., Cappell, K. M., & Whitehurst, A. W. (2014). Mechanisms promoting escape from mitotic stress-induced tumor cell death. Cancer Research, 74(14), 3857-3869. https://doi.org/10.1158/0008-5472.CAN-13-3398

Mechanisms promoting escape from mitotic stress-induced tumor cell death. / Sinnott, Rebecca; Winters, Leah; Larson, Brittany; Mytsa, Daniela; Taus, Patrick; Cappell, Kathryn M.; Whitehurst, Angelique W.

In: Cancer Research, Vol. 74, No. 14, 15.07.2014, p. 3857-3869.

Research output: Contribution to journalArticle

Sinnott, R, Winters, L, Larson, B, Mytsa, D, Taus, P, Cappell, KM & Whitehurst, AW 2014, 'Mechanisms promoting escape from mitotic stress-induced tumor cell death', Cancer Research, vol. 74, no. 14, pp. 3857-3869. https://doi.org/10.1158/0008-5472.CAN-13-3398
Sinnott R, Winters L, Larson B, Mytsa D, Taus P, Cappell KM et al. Mechanisms promoting escape from mitotic stress-induced tumor cell death. Cancer Research. 2014 Jul 15;74(14):3857-3869. https://doi.org/10.1158/0008-5472.CAN-13-3398
Sinnott, Rebecca ; Winters, Leah ; Larson, Brittany ; Mytsa, Daniela ; Taus, Patrick ; Cappell, Kathryn M. ; Whitehurst, Angelique W. / Mechanisms promoting escape from mitotic stress-induced tumor cell death. In: Cancer Research. 2014 ; Vol. 74, No. 14. pp. 3857-3869.
@article{3fdab28182894b8e824db5be86e381cf,
title = "Mechanisms promoting escape from mitotic stress-induced tumor cell death",
abstract = "Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about themolecular underpinnings of the intrinsic resistance of chemo-na{\"i}ve NSCLC. Herewe report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling ofmitotic defects fromapoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, whichmay promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.",
author = "Rebecca Sinnott and Leah Winters and Brittany Larson and Daniela Mytsa and Patrick Taus and Cappell, {Kathryn M.} and Whitehurst, {Angelique W.}",
year = "2014",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-13-3398",
language = "English (US)",
volume = "74",
pages = "3857--3869",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Mechanisms promoting escape from mitotic stress-induced tumor cell death

AU - Sinnott, Rebecca

AU - Winters, Leah

AU - Larson, Brittany

AU - Mytsa, Daniela

AU - Taus, Patrick

AU - Cappell, Kathryn M.

AU - Whitehurst, Angelique W.

PY - 2014/7/15

Y1 - 2014/7/15

N2 - Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about themolecular underpinnings of the intrinsic resistance of chemo-naïve NSCLC. Herewe report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling ofmitotic defects fromapoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, whichmay promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.

AB - Non-small cell lung cancer (NSCLC) is notorious for its paltry responses to first-line therapeutic regimens. In contrast to acquired chemoresistance, little is known about themolecular underpinnings of the intrinsic resistance of chemo-naïve NSCLC. Herewe report that intrinsic resistance to paclitaxel in NSCLC occurs at a cell-autonomous level because of the uncoupling ofmitotic defects fromapoptosis. To identify components that permit escape from mitotic stress-induced death, we used a genome-wide RNAi-based strategy, which combines a high-throughput toxicity screen with a live-cell imaging platform to measure mitotic fate. This strategy revealed that prolonging mitotic arrest with a small molecule inhibitor of the APC/cyclosome could sensitize otherwise paclitaxel-resistant NSCLC. We also defined novel roles for CASC1 and TRIM69 in supporting resistance to spindle poisons. CASC1, which is frequently co-amplified with KRAS in lung tumors, is essential for microtubule polymerization and satisfaction of the spindle assembly checkpoint. TRIM69, which associates with spindle poles and promotes centrosomal clustering, is essential for formation of a bipolar spindle. Notably, RNAi-mediated attenuation of CASC1 or TRIM69 was sufficient to inhibit tumor growth in vivo. On the basis of our results, we hypothesize that tumor evolution selects for a permissive mitotic checkpoint, whichmay promote survival despite chromosome segregation errors. Attacking this adaptation may restore the apoptotic consequences of mitotic damage to permit the therapeutic eradication of drug-resistant cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84904248445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904248445&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-13-3398

DO - 10.1158/0008-5472.CAN-13-3398

M3 - Article

C2 - 24860162

AN - SCOPUS:84904248445

VL - 74

SP - 3857

EP - 3869

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 14

ER -